Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2006
Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancerToshiaki Saeki, Tadashi Nomizu, Masakazu Toi, et al.
Cancer Medicine|October 23, 2020
Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trialMoe Tsuda, Hiroshi Ishiguro, Naoko Toriguchi, et al.
Clinical Breast Cancer|December 14, 2011
Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancerSeigo Nakamura, Masashi Ando, Norikazu Masuda, et al.
BMC Cancer|April 27, 2023
The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patientsShouko Hayama, Rikiya Nakamura, Takayuki Ishige, et al.
No Shinkei Geka. Neurological Surgery|April 9, 2016
[Usefulness and Problems of Intraoperative Monitoring for Unruptured Aneurysm Surgery with the Motor Evoked Potential]Tomotaka Ishizaki, Otone Endo, Kentaro Fujii, et al.
JMA Journal|November 9, 2023
Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health ServicesShin Takayama, Takayuki Kinoshita, Sho Shiino, et al.
Cancer Science|January 15, 2026
Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup AnalysisMasato Takahashi, Hirofumi Mukai, Toshimi Takano, et al.
Annals of Surgical Oncology|February 18, 2026
Radiofrequency Ablation for Early Stage Breast Cancer as a Potential Alternative to Partial Mastectomy: 5-Year Results from the Multiple-Center, Single-Arm, Phase 3 RAFAELO Study (NCCH1409)Takayuki Kinoshita, Shin Takayama, Tomomi Fujisawa, et al.
Breast Cancer (Tokyo, Japan)|February 16, 2020
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01Hiroyasu Yamashiro, Hiroji Iwata, Norikazu Masuda, et al.
British Journal of Cancer|July 4, 2025
Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trialTadahiko Shien, Fumikata Hara, Kenjiro Aogi, et al.
Pageof 6